Bio-Techne (TECH) Change in Taxes (2009 - 2026)
Bio-Techne (TECH) posted quarterly Change in Taxes of $9.8 million for Q1 2026, up 324.77% year-over-year from $2.3 million in Q1 2025, and up 114.01% quarter-over-quarter from $4.6 million in Q4 2025.
Analysis
Bio-Techne (TECH) Change in Taxes (2009 - 2026) Analysis & Trends
Bio-Techne's Change in Taxes history runs 18 years deep, the most recent figure standing at $9.8 million for Q1 2026.
- In Q1 2026, Change in Taxes rose 324.77% year-over-year to $9.8 million; the TTM figure through Mar 2026 stood at $3.3 million (up 118.06% YoY), while the FY2025 annual figure was $8.5 million, up 179.9% from the prior year.
- Change in Taxes for Q1 2026 stood at $9.8 million, up from $4.6 million in the prior quarter.
- The five-year high for Change in Taxes was $16.4 million in Q2 2025, with the low at -$27.4 million in Q3 2025.
- The 5-year median for Change in Taxes is $2.3 million (2025), against an average of -$523058.8.
- The sharpest annual moves came in 2023 and 2026: Change in Taxes sank 880.4% in 2023, then soared 324.77% in 2026.
- Bio-Techne's Change in Taxes stood at $10.5 million in 2022, then advanced by 24.34% to $13.1 million in 2023, then sank by 130.93% to -$4.0 million in 2024, then jumped by 213.33% to $4.6 million in 2025, then surged by 114.01% to $9.8 million in 2026.
- Business Quant data shows TECH's Change in Taxes at $9.8 million in Q1 2026, $4.6 million in Q4 2025, and -$27.4 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Bio-Techne | 11.29 Bn | 11.03 Bn | 211.39 Mn | -10.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -10.01 Mn |
| Mar 31, 2026 | 9.79 Mn |
| Dec 31, 2025 | 4.58 Mn |
| Sep 30, 2025 | -27.40 Mn |
| Jun 30, 2025 | 16.38 Mn |
| Mar 31, 2025 | 2.31 Mn |
| Dec 31, 2024 | -4.04 Mn |
| Sep 30, 2024 | -6.18 Mn |
| Jun 30, 2024 | -10.60 Mn |
| Mar 31, 2024 | 9.89 Mn |
| Dec 31, 2023 | 13.05 Mn |
| Sep 30, 2023 | -22.94 Mn |
| Jun 30, 2023 | -6.34 Mn |
| Mar 31, 2023 | -9.59 Mn |
| Dec 31, 2022 | 10.50 Mn |
| Sep 30, 2022 | 2.94 Mn |
| Jun 30, 2022 | 11.88 Mn |
| Mar 31, 2022 | -3.11 Mn |
| Dec 31, 2021 | 13.72 Mn |
| Sep 30, 2021 | -19.82 Mn |